Related Experiment Video
Updated: Jul 13, 2026

Generation of Human Monocyte-derived Dendritic Cells from Whole Blood
Published on: December 24, 2016
Peripheral-blood dendritic cells in men with coronary heart disease
Hongyu Shi1, Junbo Ge, Weiyi Fang
1Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Insights
Coronary artery disease (CAD) patients show higher levels of dendritic cells (DCs), particularly myeloid DCs (mDCs), compared to controls. This increase in mDCs may contribute to the heightened T-helper type 1 (Th1) immune response observed in CAD.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Cell Biology
Background:
- An imbalance in T-helper type 1 (Th1)/T-helper type 2 (Th2) immune responses, favoring Th1, is implicated in coronary artery disease (CAD).
- Dendritic cells (DCs), including myeloid DCs (mDCs) and plasmacytoid DCs (pDCs), are key regulators of T-helper cell differentiation and immune responses.
Purpose of the Study:
- To investigate the levels of total peripheral-blood dendritic cells (DCs) and their subsets (mDCs and pDCs) in patients with coronary artery disease (CAD).
- To determine if DC subset distribution differs between CAD patients and healthy controls, potentially explaining the skewed Th1/Th2 balance in CAD.
Main Methods:
- Peripheral blood samples were collected from 32 men undergoing coronary angiography, divided into a CAD group (n=21) and a control group (n=11).
- A 3-color flow cytometry technique was used to quantify total DCs, mDCs (Lin1(-)HLA-DR(+)CD11c(+)), and pDCs (Lin1(-)HLA-DR(+)CD123(+)).
Main Results:
- The absolute number of total peripheral-blood DCs was significantly higher in the CAD group compared to the control group (p=0.04).
- Both the percentage and absolute number of the mDC subset were significantly increased in CAD patients (p<0.05).
- The pDC fraction remained similar between groups, but the mDC/pDC ratio was significantly elevated in the CAD group (p=0.01).
Conclusions:
- Patients with coronary artery disease exhibit significantly higher numbers of total peripheral-blood dendritic cells.
- The observed increase in the myeloid DC subset in CAD patients may be a contributing factor to the enhanced Th1 immune response characteristic of the disease.
Abstract:
Accumulating evidence suggests that an imbalance in T-helper type 1 (Th1)/Th2 response with enhanced Th1 immune response has an important role in the process of coronary artery disease (CAD). Dendritic cell (DC) subsets, myeloid DCs (mDCs) and plasmacytoid DCs (pDCs), could regulate immune reactions by polarizing naive T-helper cells into Th1 or Th2 effector cells. In this study, total peripheral-blood DCs and mDC and pDC subsets were examined in patients with coronary heart disease. Thirty-two men who underwent coronary angiography for chest pain were divided into the CAD group (n = 21) and control group (normal coronary angiographic results, n = 11). Peripheral-blood DCs and DC subsets were detected using a 3-color flow cytometry technique. DCs were defined as Lin1(-)HLA-DR(+); mDCs, as Lin1(-)HLA-DR(+)CD11c(+); and pDCs, as Lin1(-)HLA-DR(+)CD123(+). The absolute number of peripheral-blood DCs was significantly higher in the CAD group compared with the control group (p = 0.04). The mDC fraction in terms of both percentage and absolute number was also significantly increased in the CAD group compared with the control group (all p <0.05), whereas the pDC fraction was similar between the 2 groups (p >0.05). The mDC/pDC ratio was significantly increased in the CAD group than in the control group (p = 0.01). In conclusion, total peripheral-blood DCs are significantly higher in patients with CAD because of an increase in mDC subset, which might contribute to enhanced Th1 response in patients with CAD.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease I: Introduction

